Study identifies new strategy to overcome immunotherapy resistance in colorectal cancer

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer, one of the leading causes of cancer-related deaths worldwide.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup